These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
56 related items for PubMed ID: 2134803
1. [Studies on suppurative lesion and bone distribution of peroral antimicrobial agents (LAPC and TFLX) to experimental infected rabbits]. Tanaka M, Satoh T. Shigaku; 1990 Oct; 78(3):527-52. PubMed ID: 2134803 [Abstract] [Full Text] [Related]
4. [Penetration into bone and joint tissues of rabbits and in vitro antibacterial activity of tosufloxacin]. Yamashiro Y, Nunome M, Takahata M, Yasuda T. Jpn J Antibiot; 1993 Jan; 46(1):31-5. PubMed ID: 8384277 [Abstract] [Full Text] [Related]
6. [Clinical efficacy of tosufloxacin on the patients with urinary tract infections]. Yoshida K, Kobayashi N, Saitoh H, Negishi T, Yamada T, Watanabe T, Kawakami S, Tari K, Satake I, Ozawa K. Hinyokika Kiyo; 1992 Jan; 38(1):129-34. PubMed ID: 1546562 [Abstract] [Full Text] [Related]
7. [Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection]. Sasaki J, Kaneko A, Karakida K, Shiiki K, Sakamoto H, Naitoh H, Yamane N, Tomita F, Katoh H, Yoshida H. Jpn J Antibiot; 1995 Sep; 48(9):1093-118. PubMed ID: 7474331 [Abstract] [Full Text] [Related]
10. [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection]. Sakurai M, Sugimura Y, Arima K, Kawamura J, Saitou K, Tajima K, Nakano S, Satani H, Nagano M, Hoshina A. Hinyokika Kiyo; 1994 Mar; 40(3):279-84. PubMed ID: 8178752 [Abstract] [Full Text] [Related]
11. [Study on the formation of experimental infected rabbit]. Satoh T, Heimdahl A. Shigaku; 1989 Apr; 76(7):1520-6. PubMed ID: 2761965 [Abstract] [Full Text] [Related]
13. In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Thadepalli H, Reddy U, Chuah SK, Thadepalli F, Malilay C, Polzer RJ, Hanna N, Esfandiari A, Brown P, Gollapudi S. Antimicrob Agents Chemother; 1997 Mar; 41(3):583-6. PubMed ID: 9055997 [Abstract] [Full Text] [Related]
14. [Clinical studies of tosufloxacin on chronic bacterial prostatitis]. Ikeuchi T, Kawamura N, Suzuki K, Onodera S, Osada T, Hirano A, Satomi Y, Yoshimura S, Yamamoto Y. Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691 [Abstract] [Full Text] [Related]
15. [Preventive chemotherapy after transurethral prostatectomy: a randomized study]. Yoshida O, Arai Y, Takeuchi H, Fukuyama T, Hida S, Ikeda T, Okabe T, Kuo SY, Kounami T, Nakagawa T. Hinyokika Kiyo; 1993 May; 39(5):491-6. PubMed ID: 7686715 [Abstract] [Full Text] [Related]
16. Cortical bone concentrations of enrofloxacin in dogs. Duval JM, Budsberg SC. Am J Vet Res; 1995 Feb; 56(2):188-92. PubMed ID: 7717584 [Abstract] [Full Text] [Related]
17. [Concentrations of new quinolone agents in serum and prostate tissue]. Imai K, Suzuki K, Yamanaka H, Makino T, Yazima H, Takezawa Y, Kitaura K, Shiono A, Sato J, Kato N. Hinyokika Kiyo; 1994 May; 40(5):401-6. PubMed ID: 7517621 [Abstract] [Full Text] [Related]